Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
55.06
-5.54 (-9.14%)
At close: Nov 13, 2024, 4:00 PM
55.73
+0.67 (1.22%)
After-hours: Nov 13, 2024, 7:53 PM EST
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $6.14 billion as of November 13, 2024. Its market cap has increased by 540.27% in one year.
Market Cap
6.14B
Enterprise Value
5.21B
1-Year Change
540.27%
Ranking
Category
Stock Price
$55.06
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $6.14B, an increase of 7,817.02%. That is a compound annual growth rate of 58.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2024 | 6.75B | 262.77% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Legend Biotech | 7.40B |
| Madrigal Pharmaceuticals | 7.39B |
| Grifols | 7.10B |
| Elanco Animal Health | 6.98B |
| Bausch + Lomb | 6.88B |
| Cytokinetics | 6.63B |
| Nuvalent | 6.42B |
| RadNet | 6.18B |